Hydrochlorothiazide.
Hydrochlorothiazide (HCTZ) is a thiazide diuretic widely used for hypertension and edema. It is a sulfonamide derivative — it contains the –SO2NH2 group — but it is not an antibiotic, and lacks the N4 arylamine that drives most antibiotic-type immune reactivity. Cross-reactivity with sulfa antibiotic allergy is low; photosensitivity is a clinically meaningful side effect.
- Class
- Thiazide diuretic — inhibitor of the
Na+-Cl−cotransporter (NCC) in the distal tubule. - Common indications
- Hypertension, mild heart failure with edema, kidney stone prevention, certain forms of diabetes insipidus.
- Sulfa allergy
- Low cross-reactivity with sulfa antibiotics in published data.
- Photosensitivity
- Notable — routine sun precautions are appropriate.
What it does
HCTZ blocks the Na+-Cl− cotransporter (NCC) on the apical membrane of cells in the distal convoluted tubule of the kidney. Reabsorption of sodium and chloride from the urine is reduced, producing a moderate diuresis. The antihypertensive effect at low doses is partly through volume reduction and partly through other mechanisms not fully understood (changes in vascular tone over time).
HCTZ is less powerful as a diuretic than the loop diuretics (furosemide and others), and its diuretic effect plateaus at modest doses. For volume overload in heart failure, loop diuretics are preferred. For uncomplicated hypertension, low-dose thiazides are a long-standing first-line option in many guidelines. Sulfa diuretics covers the broader class.
What it is used for
Hypertension. Among the most prescribed antihypertensive drugs in the world. Often combined with an ACE inhibitor or ARB in fixed-dose formulations. Modern comparative evidence has raised questions about whether chlorthalidone (a related thiazide-like agent) may have advantages over HCTZ at typical clinical doses, but HCTZ remains widely used.
Edema. Mild peripheral edema in heart failure, often combined with a loop diuretic when needed for synergistic effect.
Kidney stone prevention. Thiazides reduce urinary calcium excretion, lowering the risk of recurrent calcium oxalate stones in selected patients.
Diabetes insipidus. Counterintuitively, thiazides reduce urine output in nephrogenic and central diabetes insipidus, through a complex mechanism involving volume contraction and altered tubular handling of water.
Common adverse effects
Most expected effects relate to the pharmacology:
Electrolyte changes — hypokalemia, hyponatremia (more common in older patients and at higher doses), occasionally hypomagnesemia. Hypercalcemia (paradoxical to a stone-preventing drug, but in a different way: serum calcium can rise because urinary loss is reduced).
Hyperuricemia and gout — thiazides raise serum urate and can precipitate gout.
Mild hyperglycemia — thiazides can modestly raise fasting blood glucose, particularly at higher doses.
Dyslipidemia — small increases in total cholesterol and triglycerides have been reported.
Photosensitivity — clinically important. HCTZ is among the more notable photosensitising drugs in routine prescribing. Photosensitivity covers the practical points.
Less common: rash (sometimes photosensitive in pattern), rare blood dyscrasias, rare pancreatitis, very rare interstitial nephritis. Long-term thiazide use has been associated in some pharmacoepidemiology studies with an increased risk of non-melanoma skin cancer (squamous and basal cell carcinoma), thought to relate to photosensitivity over years; the absolute increase is small but the signal has prompted public-facing warnings in some jurisdictions.
The sulfa allergy question
HCTZ contains the sulfonamide group but lacks an N4 arylamine. Published data show low cross-reactivity with sulfa antibiotic allergy. More on the data; common cross-reactivity questions covers the recurring patient queries directly.
Most prescribers will use HCTZ in patients with a documented mild sulfa antibiotic allergy. Patients with severe past reactions are managed individually. Photosensitivity reactions on HCTZ — distinct from cross-reactivity — should not be misinterpreted as evidence that "the sulfa is bothering me again."
Interactions
HCTZ interacts with several other drugs. Of clinical note: increased lithium levels (close monitoring required); additive electrolyte loss with other diuretics; reduced antihypertensive effect with NSAIDs; potentiation of digoxin toxicity through hypokalemia; increased calcium with vitamin D supplementation. The pharmacist's review at prescribing time matters.